First-line Gemcitabine/Cisplatin +/- Avelumab in Locally Advanced or Metastatic Bladder Carcinoma
Clinical trial NCT03324282 · TERMINATED
Trial details
- NCT number
- NCT03324282
- Sponsor
- University Hospital, Bordeaux
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-23
- Primary completion
- 2021-12-31
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.